ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,930.85
1.09%
US Tech 100
20,836.00
1.31%
Dow Jones
42,840.26
1.18%
Brent Oil
72.72
0.00%
Bitcoin
97,501.31
-0.26%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NYSE

  6. Solventum Corporation (SOLV) Quote

Solventum Corporation

Solventum Corporation (SOLV)

SolVBL Solutions Inc
Solvac SA
66.83
0.03
(0.04%)
Closed December 21 4:00PM
Delayed by 15 minutes
66.83
0.00
(0.00%)
After Hours: 7:09PM
Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
66.83
Bid
-
Ask
-
Volume
1,798,749
66.2846 Day's Range 67.50
47.16 52 Week Range 76.4306
Market Cap
11.545B
Previous Close
66.80
Open
66.58
Last Trade
609877
@
66.83
Last Trade Time
Financial Volume
$ 120,294,259
VWAP
66.8766
Average Volume (3m)
942,415
Shares Outstanding
172,754,070
Dividend Yield
-
PE Ratio
16.68
Earnings Per Share (EPS)
4.01
Revenue
8.24B
Net Profit
692M

About Solventum Corporation

Solventum originates from two words: 'solving' and 'momentum.'Solving' captures the company's dedication to finding breakthrough solutions. The organization will listen closely to health care professionals and never stop solving for them -and the many lives they enhance globally. 'Momentum' symboliz... Solventum originates from two words: 'solving' and 'momentum.'Solving' captures the company's dedication to finding breakthrough solutions. The organization will listen closely to health care professionals and never stop solving for them -and the many lives they enhance globally. 'Momentum' symbolizes swifter, nimbler innovation. As the independent health care company builds on every achievement, large and small, its momentum propels it past barriers, towards breakthroughs. The new name represents how the independent health care company will focus on solving big health care challenges and emphasizes the tremendous impact it can make on the world. Show more

Sector
Surgical,med Instr,apparatus
Industry
Surgical,med Instr,apparatus
Website
www.solventum.com
Headquarters
Wilmington, Delaware, USA
Founded
-
Solventum Corporation is listed in the Surgical,med Instr,apparatus sector of the New York Stock Exchange with ticker SOLV. The last closing price for Solventum was $66.80. Over the last year, Solventum shares have traded in a share price range of $ 47.16 to $ 76.4306.

Solventum currently has 172,754,070 shares outstanding. The market capitalization of Solventum is $11.54 billion. Solventum has a price to earnings ratio (PE ratio) of 16.68.

Ask ADVFN Intelligence (AI)

SOLV Latest News

More News

Form EFFECT - Notice of Effectiveness

December 18 2024
Edgar (US Regulatory)

Form POS AM - Post-Effective amendments for registration statement

December 11 2024
Edgar (US Regulatory)

Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]

December 10 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

December 03 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

December 03 2024
Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness

December 03 2024
Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]

December 02 2024
Edgar (US Regulatory)

Solventum to Participate in the Piper Sandler Healthcare Conference

Solventum to Participate in the Piper Sandler Healthcare Conference PR Newswire ST. PAUL, Minn., Nov. 19, 2024 ST. PAUL, Minn., Nov. 19, 2024 /PRNewswire/ -- Solventum (NYSE: SOLV) announced...

November 19 2024
PR Newswire (US)

Form S-4 - Registration of securities, business combinations

November 15 2024
Edgar (US Regulatory)

Solventum Launches First 3D Printed Aligner Attachments to Revolutionize Aligner Treatment

Solventum Launches First 3D Printed Aligner Attachments to Revolutionize Aligner Treatment PR Newswire ST. PAUL, Minn., Nov. 14, 2024 Clarity Precision Grip Attachments are fully cured...

November 14 2024
PR Newswire (US)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-2.55-3.675410781269.3870.3466.2176774168.09482038CS
4-3.43-4.8818673498470.2672.80566.2182158770.16312024CS
12-1.58-2.3096038590868.4176.430665.9594241570.44607126CS
2613.8926.237249716752.9476.430647.16124786962.46256314CS
52-2.32-3.355025307369.1576.430647.16160659662.83192552CS
156-2.32-3.355025307369.1576.430647.16160659662.83192552CS
260-2.32-3.355025307369.1576.430647.16160659662.83192552CS

SOLV - Frequently Asked Questions (FAQ)

What is the current Solventum share price?
The current share price of Solventum is $ 66.83
How many Solventum shares are in issue?
Solventum has 172,754,070 shares in issue
What is the market cap of Solventum?
The market capitalisation of Solventum is USD 11.54B
What is the 1 year trading range for Solventum share price?
Solventum has traded in the range of $ 47.16 to $ 76.4306 during the past year
What is the PE ratio of Solventum?
The price to earnings ratio of Solventum is 16.68
What is the cash to sales ratio of Solventum?
The cash to sales ratio of Solventum is 1.4
What is the reporting currency for Solventum?
Solventum reports financial results in USD
What is the latest annual turnover for Solventum?
The latest annual turnover of Solventum is USD 8.24B
What is the latest annual profit for Solventum?
The latest annual profit of Solventum is USD 692M
What is the registered address of Solventum?
The registered address for Solventum is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Solventum website address?
The website address for Solventum is www.solventum.com
Which industry sector does Solventum operate in?
Solventum operates in the SURGICAL,MED INSTR,APPARATUS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
VNCEVince Holding Corp
$ 4.70
(69.06%)
1.06M
SRFMSurf Air Mobility Inc
$ 3.33
(23.79%)
376.77k
BBBlackBerry Limited
$ 3.685
(23.66%)
40.8M
ALURAllurion Technologies Inc
$ 0.3439
(22.87%)
744.34k
CLWClearWater Paper Corporation
$ 30.26
(22.46%)
3.5M
IIPRInnovative Industrial Properties Inc
$ 73.50
(-22.91%)
3.15M
KUKEKuke Music Holding Limited
$ 0.31
(-20.51%)
61.21k
NVONovo Nordisk
$ 85.00
(-17.83%)
53.78M
CANGCango Inc
$ 5.08
(-11.81%)
2.27M
BNEDBarnes and Noble Education Inc
$ 9.965
(-10.31%)
1.52M
QBTSD Wave Quantum Inc
$ 6.638
(4.21%)
124.42M
PFEPfizer Inc
$ 26.36
(2.29%)
116.33M
APOApollo Global Management Inc
$ 171.03
(0.83%)
94.52M
TAT&T Inc
$ 22.75
(0.80%)
93.94M
FFord Motor Company
$ 9.885
(1.49%)
87.66M

SOLV Discussion

View Posts
DewDiligence DewDiligence 1 month ago
SOLV 3Q24 Results by Business Segment
%Corp YoY Growth
Segment Sales Organic Sales†
Medical/surgical* 57% +1%
Dental 15% -4%
Health-info systems 16% +2%
Purification/filtration 11% 0% †Excludes acquisitions, divestitures, and currency.

*Includes components for other companies’ medical devices.
👍️0
DewDiligence DewDiligence 1 month ago
SOLV reports 3Q24 results—raises 2024 guidance…

New 2024 guidance is as follows:

• Non-GAAP EPS of $6.50-6.65 (vs prior guidance of $6.30-6.50).

• Organic sales growth of 0.5-1.0% (vs prior guidance of 0-1%).

• FCF of $750-850M (vs prior guidance of $700-800M).

At the current share price (~$77 as I’m typing), the midpoint of the new 2024 non-GAAP EPS guidance range represents a P/E ratio of 11.7x.


PR:
https://investors.solventum.com/image/2024-11-07-Solventum-Reports-Third-Quarter-2024-Financial-Results-and-Raises-Full-Year-Guidance.pdf

CC slides:
https://investors.solventum.com/image/SOLV+Q3+2024+Earnings+Presentation.pdf
👍️0
DewDiligence DewDiligence 2 months ago
SOLV seeking buyer for filtration business, according to WSJ sources:

https://www.wsj.com/business/deals/recent-3m-spinoff-explores-sale-of-filtration-unit-f331a83d

In 2Q24, the filtration segment comprised 12% of SOLV’s sales, but the growth rate was non-existent (#msg-174889792).
👍️0
DewDiligence DewDiligence 2 months ago
SOLV hires CMO:

https://finance.yahoo.com/news/solventum-names-surgeon-diagnostics-pioneer-130000072.html
👍️0
DewDiligence DewDiligence 4 months ago
SOLV 2Q24 CC slides:

https://investors.solventum.com/image/Q2+2024+Earnings+Presentation+-+FINAL+8.8.24.pdf
👍️0
DewDiligence DewDiligence 4 months ago
SOLV 2Q24 Results by Business Segment
%Corp YoY Growth
Segment Sales Organic Sales†
Medical/surgical* 56% +2%
Dental 16% -2%
Health-info systems 16% +4%
Purification/filtration 12% -1% †Excludes acquisitions, divestitures, and currency.

*Includes components for other companies’ medical devices.
👍️0
DewDiligence DewDiligence 4 months ago
SOLV’s raised 2024 guidance is as follows:

https://finance.yahoo.com/news/solventum-reports-second-quarter-2024-200500242.html

• 2024 organic sales growth of 0-1% (up from the prior range of -2% to 0%).

• 2024 non-GAAP EPS of $6.30-6.50 (up from the prior range of $6.10-6.40).

At the current share price ($60.00 as I’m typing), the midpoint of the new 2024 non-GAAP EPS guidance range represents a P/E ratio of 9.4x.
👍️0
abrooklyn abrooklyn 4 months ago
Solventum Reports Second Quarter 2024 Financial Results and Raises Full-Year Guidance

Source: PR Newswire (US)
Separation activities and business continuity on track
Reported sales increased 0.2% to $2.081 billion; organic sales increased 1.3%
GAAP Earnings Per Share (EPS) of $0.51; adjusted EPS1 of $1.56
Generated $355 million in cash from operations; free cash flow1 of $297 million
Raises full-year 2024 organic sales growth and adjusted EPS guidance
ST. PAUL, Minn., Aug. 8, 2024 /PRNewswire/ -- Solventum (NYSE: SOLV) today reported financial results as a stand-alone company for the second quarter ended June 30, 2024.

Solventum Logo (PRNewsfoto/3M Healthcare US Opco LLC)

"As we continue to execute a complex transformation, we're encouraged by our first financial results as an independent company and early ability to maintain business continuity," said?Bryan Hanson, chief executive officer, Solventum. "We are starting from a solid foundation and remain focused on addressing historical underperformance and spin-related topics to unlock significant value creation over time."
👍️ 1
DewDiligence DewDiligence 5 months ago
Activist_investor_builds_stake_in SOLV—(3M’s healthcare spinoff):

https://finance.yahoo.com/news/peltz-trian-building-stake-3m-230900848.html
👍️0
DewDiligence DewDiligence 6 months ago
SOLV 1Q24 Results by Business Segment
%Corp YoY Growth
Segment Sales (const currency)
Medical/surgical* 56% flat
Dental 17% flat
Health-info systems 16% flat
Purification/filtration 12% +7% *Includes components for other companies’ medical devices.
👍️0
DewDiligence DewDiligence 6 months ago
SOLV’s “AI play”—>heath-information systems segment:

https://finance.yahoo.com/news/solventum-introduces-denials-prevention-solution-130000721.html

Heath-information systems comprised 16% of SOLV’s overall (pro forma) sales in 1Q24 (#msg-174387294), but SOLV expects this figure to steadily increase due to the application of AI.
👍️0
KingOfSwing...Trading KingOfSwing...Trading 7 months ago
Thank for the excellent post. Very useful.
👍️0
DewDiligence DewDiligence 7 months ago
SOLV reports pro forma 1Q24 results—reiterates 2024 guidance:

https://finance.yahoo.com/news/solventum-reports-first-quarter-2024-105000516.html

SOLV was spun out of 3M on 4/1/24, so the 1Q24 financial results are pro forma based on what SOLV would have reported if it had it been an independent company.

SOLV re-iterated 2024 guidance given on 3/19/24—see #msg-174067513. (2024 guidance includes the pro forma financials for 1Q24 and actual SOLV results for the remainder of the year.)

The only consequential update is that SOLV is not initiating a dividend, so that free cash flow can be directed toward paying down debt. This decision is not surprising in light of the large debt load SOLV took on as part of the spinoff from 3M.

p.s. No 1Q24 CC due to the Investor Day webcast just a few weeks ago.
👍️0
Porgie Tirebiter Porgie Tirebiter 9 months ago
All of a sudden, I own shares of SOLV! I guess I should have been paying more attention to 3M.

I've had 3M for years and years, just collecting the dividend and probably not paying enough attention to it!
👍️0
DewDiligence DewDiligence 9 months ago
SOLV begins trading on NYSE following completion of spinoff from 3M:

https://finance.yahoo.com/news/solventum-begins-trading-york-stock-103000676.html
👍️ 1
DewDiligence DewDiligence 9 months ago
SOLV Investor Day CC slides:

https://d1io3yog0oux5.cloudfront.net/_7984eceea22d0dd69e55aae6e648ee7c/3m/db/3194/30840/presentation/Solventum+Investor+Day+3.19.2024.pdf
👍️ 1
DewDiligence DewDiligence 9 months ago
SOLV issues 2024 guidance:

https://finance.yahoo.com/news/solventum-hosts-inaugural-investor-day-103000871.html

• Organic revenue growth of -2% to 0%

• Adjusted earnings per share (EPS) of $6.10 to $6.40

• Free cash flow of $700M to $800M
👍️ 1
DewDiligence DewDiligence 9 months ago
Details of 3M’s SOLV spinoff finalized:

https://finance.yahoo.com/news/3m-board-directors-approves-spin-165500127.html

3M shareholders of record on 3/18/24 will receive 1 share of SOLV for every 4 shares of 3M. The SOLV shares will be distributed before the market open on 4/1/24.

This is a tax-exempt distribution for US residents.
👍️0
DewDiligence DewDiligence 10 months ago
SOLV sells $6.9B of debt in six tranches:

• $1B of 3yr notes @5.45%

• $1.5B of 5yr notes @5.40%

• $1B of 7yr notes @5.45%

• $1.65B of 10yr notes @5.60%

• $1.25B of 30yr notes @5.90%

• $0.5B of 40yr notes @6.00%

The total debt issuance was supposed to $8.4B (according to 3M's recent webcast), but I don't know where the other $1.5B is coming from.

All but $600M of the proceeds will be paid to 3M as consideration for the spin-off of 3M’s healthcare business to SOLV.
👍️ 1
DewDiligence DewDiligence 10 months ago
SOLV is holding an Investor Day webcast 3/19/24 at 9am ET.
👍️0
DewDiligence DewDiligence 10 months ago
These are the five focal areas for 3M’s healthcare business that will become part of Solventum; they comprise about 25% of 3M’s current company-wide sales:

https://engage.3m.com/purification

https://www.3m.com/3M/en_US/health-information-systems-us/

https://www.3m.com/3M/en_US/medical-us/ (surgical supplies and wound care)

https://www.3m.com/3M/en_US/medical-device-components-us/ (components for other companies’ medical devices)

https://www.3m.com/3M/en_US/oral-care-us/ (dentistry and othodontics)
👍️0
DewDiligence DewDiligence 10 months ago
Further details of 3M/SOLV capitalization:

SOLV will sell $8.4B of new debt, keeping $600M of the proceeds and paying $7.7B as a one-time (tax-free) dividend to 3M. (~$100M of the debt proceeds will go to underwriting fees.)

After the debt issuance and one-time payment to 3M, SOLV will have a debt/EBITDA ratio of ~3.5.
👍️0
DewDiligence DewDiligence 10 months ago
3M sets 4/1/24 date for Solventum spin-off:

https://d1io3yog0oux5.cloudfront.net/_28c5051c41e86ce7771a2dfe11a5ee94/3m/news/2024-02-21_3M_Announces_Filing_of_Form_10_Registration_1826.pdf
👍️0

Your Recent History

NYSE
SOLV
Solventum
LBNK
GRAILUSDT
Camelot token
LSE
94YZ
Arab Rep.egp49s
AMEX
BAMY
Brookstone Yield ETF
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads